These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36774433)

  • 1. Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors.
    Partelli S; Andreasi V; Peralta Ferreira M; Palumbo D; Muffatti F; Battistella A; Fermi F; Mapelli P; Tamburrino D; Pecorelli N; Crippa S; Falconi M
    Ann Surg Oncol; 2023 Jun; 30(6):3466-3477. PubMed ID: 36774433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms.
    Guarneri G; de Mestier L; Landoni L; Partelli S; Gaujoux S; Andreasi V; Nessi C; Dokmak S; Fontana M; Dousset B; Ruszniewski P; Bassi C; Falconi M; Sauvanet A
    Neuroendocrinology; 2021; 111(8):728-738. PubMed ID: 32585667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
    Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
    Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
    Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
    JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
    Sahara K; Tsilimigras DI; Mehta R; Moro A; Paredes AZ; Lopez-Aguiar AG; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho C; Beems M; Dillhoff M; Maithel SK; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Lymph Node Resection and Histopathological Evaluation in Accurate Staging of Nonfunctional Pancreatic Neuroendocrine Tumors: How Many Are Enough?
    Ding D; Javed AA; Yuan C; Wright MJ; Javed ZN; Teinor JA; Ye IC; Burkhart RA; Cameron JL; Weiss MJ; Wolfgang CL; He J
    J Gastrointest Surg; 2021 Feb; 25(2):428-435. PubMed ID: 32026333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
    Zhang XF; Xue F; Dong DH; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Lv Y; Maithel SK; Pawlik TM
    Ann Surg; 2021 Jul; 274(1):e28-e35. PubMed ID: 31356277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
    Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
    Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.
    Postlewait LM; Ethun CG; Baptiste GG; Le N; McInnis MR; Cardona K; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK
    J Surg Oncol; 2016 Sep; 114(4):440-5. PubMed ID: 27334541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single-center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Partelli S; Muffatti F; Andreasi V; Giannone F; Rossi G; Palumbo D; Mapelli P; Schiavo Lena M; Arcidiacono PG; De Cobelli F; Picchio M; Doglioni C; Falconi M
    Ann Surg; 2022 Nov; 276(5):921-928. PubMed ID: 35930017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.
    Kang MJ; Jang JY; Chang YR; Kwon W; Jung W; Kim SW
    Ann Surg Oncol; 2014 May; 21(5):1545-51. PubMed ID: 24419758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.
    Wu L; Sahara K; Tsilimigras DI; Maithel SK; Poultsides GA; Rocha FG; Weber SM; Fields RC; Idrees K; Cho CS; Shen F; Pawlik TM;
    J Surg Oncol; 2019 Dec; 120(7):1080-1086. PubMed ID: 31468550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed Tomography Features Predictive of Lymph Node Involvement in Patients With a Nonfunctioning Pancreatic Neuroendocrine Tumor.
    Choi SH; Kim HJ; Kim SY; Byun JH; Kim KW; Song KB; Kim SC; Kim MH
    Pancreas; 2017 Sep; 46(8):1056-1063. PubMed ID: 28787330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
    Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
    Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
    Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection.
    Curran T; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
    J Gastrointest Surg; 2015 Jan; 19(1):152-60; discussion 160. PubMed ID: 25118642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
    Birnbaum DJ; Viganò L; Russolillo N; Langella S; Ferrero A; Capussotti L
    Ann Surg Oncol; 2015 Mar; 22(3):811-8. PubMed ID: 25201500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study.
    Zhang P; Li YL; Qiu XD; Luo J; Shi YF; Sun YL; Su F; Qi ZR; Tan HY
    World J Surg Oncol; 2019 Apr; 17(1):66. PubMed ID: 30975157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
    Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.